n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride has been researched along with Genetic Predisposition in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Dambrova, M; Kupats, E; Lauberte, L; Mezapuke, R; Stelfa, G; Svalbe, B; Vavers, E; Vilks, K; Zvejniece, B; Zvejniece, L | 1 |
1 other study(ies) available for n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride and Genetic Predisposition
Article | Year |
---|---|
Genetic inactivation of the sigma-1 chaperone protein results in decreased expression of the R2 subunit of the GABA-B receptor and increased susceptibility to seizures.
Topics: Animals; Anisoles; Bicuculline; Convulsants; Gene Expression; Genetic Predisposition to Disease; Habenula; Hippocampus; Mice; Mice, Knockout; Nitric Oxide Synthase Type II; Pentylenetetrazole; Propylamines; Receptors, GABA-A; Receptors, GABA-B; Receptors, sigma; Seizures; Sigma-1 Receptor | 2021 |